Apellis Pharmaceuticals Aktie
18,46
EUR
+0,50
EUR
+2,76
%
18,65
USD
-0,05
USD
-0,27
%
Werbung
Apellis Pharmaceuticals Aktie Analyse
01.08.19 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
30.07.18 | Apellis Pharmaceuticals Buy | B. Riley FBR | |
24.05.18 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
12.04.18 | Apellis Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
08.02.18 | Apellis Pharmaceuticals Buy | B. Riley FBR, Inc. |
Werbung
Werbung